HfO₂–ZrO₂ Superlattice HZO Ultrathin Poly-Si Channel (3.5 nm) Junctionless FeTFTs Exhibiting Superior Endurance and Robust Retention
IEEE Transactions on Electron Devices · 2025-04 · 72 (4) · 1756-1762
DOI: 10.1109/ted.2025.3544188 ↗Kurz gefasst
Fachartikel in der Zeitschrift IEEE Transactions on Electron Devices, 2025-04. Verfasst von Dong-Ru Hsieh und 8 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Science and Technology Council (NSTC), Taiwan, Taiwan Semiconductor Research Institute (TSRI), Hsinchu, Taiwan, Materials Analysis Technology Inc., (MA-tek), Taiwan.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Science and Technology Council (NSTC), Taiwan
- Taiwan Semiconductor Research Institute (TSRI), Hsinchu, Taiwan
- Materials Analysis Technology Inc., (MA-tek), Taiwan
- Nano Facility Center (NFC), Hsinchu, Taiwan
Zitieren
APA
Hsieh, D., Hong, Z., Luo, H., Yeh, W., Ni, J., Chen, C., Lin, Y., Lo, S., & Chao, T. (2025). HfO₂–ZrO₂ Superlattice HZO Ultrathin Poly-Si Channel (3.5 nm) Junctionless FeTFTs Exhibiting Superior Endurance and Robust Retention. IEEE Transactions on Electron Devices, 72(4), 1756-1762. https://doi.org/10.1109/ted.2025.3544188
Vancouver
Hsieh D, Hong Z, Luo H, Yeh W, Ni J, Chen C, et al. HfO₂–ZrO₂ Superlattice HZO Ultrathin Poly-Si Channel (3.5 nm) Junctionless FeTFTs Exhibiting Superior Endurance and Robust Retention. IEEE Transactions on Electron Devices. 2025;72(4):1756-1762. doi:10.1109/ted.2025.3544188
BibTeX
@article{Hsieh2025,
author = {Hsieh, Dong-Ru and Hong, Zi-Yang and Luo, Huai-En and Yeh, Wei-Ju and Ni, Jia-Chian and Chen, Ciao-Fen and Lin, Yen-Fu and Lo, Shun-Tsung and Chao, Tien-Sheng},
title = {HfO₂–ZrO₂ Superlattice HZO Ultrathin Poly-Si Channel (3.5 nm) Junctionless FeTFTs Exhibiting Superior Endurance and Robust Retention},
journal = {IEEE Transactions on Electron Devices},
year = {2025},
volume = {72},
number = {4},
pages = {1756--1762},
doi = {10.1109/ted.2025.3544188}
}
EUVIMED